Research

Medical Research Study published in recent years

Kosmas CE, Silverio D, Sourlas A, Montan PD, Guzman E, Garcia MJ: Anti-inflammatory therapy for cardiovascular disease. Ann Transl Med 2019 (In press). Kosmas CE, Silverio D, Sourlas A, Montan PD, Guzman E: Dysfunctional high-density lipoprotein and atherogenesis. Vessel Plus 2019;3:2. Kosmas CE, Silverio D, Sourlas A, Montan PD, Guzman E: Role of spironolactone in the treatment of heart failure with preserved ejection fraction. Ann Transl Med 2018;6(23):461. Kosmas CE, Silverio D, Sourlas A, Garcia F, Montan PD, Guzman E: Impact of lipidlowering therapy on glycemic control and the risk for new-onset diabetes mellitus. Drugs Context 2018;7:212562. Kosmas CE, Silverio D, Ovalle J, Montan PD, Guzman E: Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemia. Patient Prefer Adherence 2018;12:2263-2266. Kosmas CE, Silverio D, Sourlas A, Garcia F, Montan PD, Guzman E: Primary genetic disorders affecting high density lipoprotein (HDL). Drugs Context 2018;7:212546. Kosmas CE, Silverio D, Tsomidou C, Salcedo MD, Montan PD, Guzman E: The impact of insulin resistance and chronic kidney disease on inflammation and cardiovascular disease. Clin Med Insights Endocrinol Diabetes 2018;11:1179551418792257. Kosmas CE, Muñoz Estrella A, Sourlas A, Silverio D, Hilario E, Montan PD, Guzman E: Inclisiran: a new promising agent in the management of hypercholesterolemia. Diseases 2018;6(3). pii: E63. Kosmas CE, Sourlas A, Bouza KV, DeJesus E, Silverio D, Montan PD, Guzman E: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with evolocumab: powerful lowdensity lipoprotein cholesterol (LDL-C) lowering and improved cardiovascular outcomes without an increase in the risk of diabetes mellitus. Ann Transl Med 2018;6(7):130. Kosmas CE, Martinez I, Sourlas A, Bouza KV, Campos FN, Torres V, Montan PD, Guzman E: High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs Context 2018;7:212525. Guzman E, Silverio D, Martinez I, Hilario E, Salcedo MD, Montan PD, Kosmas CE: Association of obstructive sleep apnea with aortic dilatation in hypertensive men of Dominican descent in an outpatient clinic. Enliven: Clin Cardiol Res 2018;5(1):001. Silverio D, Martinez I, Hilario E, Morcelo R, Fabian W, Montan PD, Guzman E, Kosmas CE: Cardiovascular effects of obstructive sleep apnea. Enliven: Clin Cardiol Res 2018;5(e1):001. Kosmas CE, Morcelo R, Martinez I, Peña Polanco V, Hilario E, Hernandez N, Montan PD, Guzman E: Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): a new promising approach for the management of hypercholesterolemia. Enliven: Clin Cardiol Res 2017;4(e1):001. Kosmas CE, DeJesus E, Morcelo R, Garcia F, Montan PD, Guzman E: Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy. Drugs Context 2017;6:212511. Kosmas CE, Morcelo R, Martinez I, Rosario D, Hernandez N, Montan PD, Guzman E: Pattern of non-adherence to statins in patients of Dominican descent in an outpatient setting. Enliven: Clin Cardiol Res 2017;4(1):001. Kosmas CE, Martinez I, Morcelo R, Fabian W, Montan PD, Guzman E: Autosomal recessive hypercholesterolemia: a rare cause of familial hypercholesterolemia. Biomed J Sci & Tech Res 2017;1(5):1-3. DOI: 10.26717/BJSTR.2017.01.000466 Kosmas CE, DeJesus E, Sourla E, Morcelo R, Montan PD, Guzman E: Effects of statins on cardiovascular outcomes in patients with chronic kidney disease. Clin Med Insights Ther 2017;9:1-5. DOI: 10.1177/1179559X17719029. Kosmas CE, Arjona C, DeJesus E, Rosario D, Tsomidou C, Vittorio TJ, Guzman E: Alirocumab in the treatment of hypercholesterolemia. Clin Med Rev Ther 2017;9:1-5. DOI: 10.1177/1179255817690768.